Comprehensive disease modeling can be challenging for many labs due to variations in reagents, cell culture conditions, technical inconsistencies across protocols and experiments and bandwidth limitations. These limitations make it challenging to model the heterogeneity in clinical phenotypes and the underlying genotypes in genetic diseases.
Download this app note to discover how a cell engineering platform can:
- Deliver robust CRISPR engineered cells
- Enable scientists to achieve desired genotypes and high-quality cell models at an affordable cost
- Leverage automated and highly standardized processes for consistent editing
